BioSpace News Archive

Press Releases

BrainChild Bio, Inc. to Clinically Advance BCB-276, an Autologous B7-H3 Targeting CAR T-cell Therapy for Incurable Pediatric Brain Tumors

January 7, 2025
·
5 min read
Press Releases

Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials

January 7, 2025
·
4 min read
Press Releases

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025
·
4 min read
Press Releases

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

January 7, 2025
·
6 min read
Press Releases

Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens

January 7, 2025
·
2 min read
Press Releases

Nuclein’s DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team

January 7, 2025
·
3 min read
Press Releases

FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway

January 7, 2025
·
3 min read
Press Releases

electroCore Expands Intellectual Property Portfolio

January 7, 2025
·
4 min read
Press Releases

ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025
·
1 min read
Press Releases

Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director

January 7, 2025
·
6 min read